These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7592905)

  • 1. Enhanced affinities and specificities of consolidated ligands for the Src homology (SH) 3 and SH2 domains of Abelson protein-tyrosine kinase.
    Cowburn D; Zheng J; Xu Q; Barany G
    J Biol Chem; 1995 Nov; 270(45):26738-41. PubMed ID: 7592905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexibility of interdomain contacts revealed by topological isomers of bivalent consolidated ligands to the dual Src homology domain SH(32) of abelson.
    Xu Q; Zheng J; Xu R; Barany G; Cowburn D
    Biochemistry; 1999 Mar; 38(12):3491-7. PubMed ID: 10090735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
    Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
    Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Abl SH2-kinase linker naturally adopts a conformation competent for SH3 domain binding.
    Chen S; Brier S; Smithgall TE; Engen JR
    Protein Sci; 2007 Apr; 16(4):572-81. PubMed ID: 17327393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
    Juang JL; Hoffmann FM
    Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.
    LaFevre-Bernt M; Sicheri F; Pico A; Porter M; Kuriyan J; Miller WT
    J Biol Chem; 1998 Nov; 273(48):32129-34. PubMed ID: 9822689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domain interactions in protein tyrosine kinase Csk.
    Sondhi D; Cole PA
    Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dissection of the interaction between the SH3 domain and the SH2-Kinase Linker region in PTK6.
    Kim HIe; Jung J; Lee ES; Kim YC; Lee W; Lee ST
    Biochem Biophys Res Commun; 2007 Nov; 362(4):829-34. PubMed ID: 17822667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains.
    Fernandez-Ballester G; Blanes-Mira C; Serrano L
    J Mol Biol; 2004 Jan; 335(2):619-29. PubMed ID: 14672668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH2 and SH3 domains: potential targets for anti-cancer drug design.
    Smithgall TE
    J Pharmacol Toxicol Methods; 1995 Nov; 34(3):125-32. PubMed ID: 8573762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific intermolecular association between the regulatory domains of a Tec family kinase.
    Brazin KN; Fulton DB; Andreotti AH
    J Mol Biol; 2000 Sep; 302(3):607-23. PubMed ID: 10986122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
    Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
    J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for specificity switching of the Src SH2 domain.
    Kimber MS; Nachman J; Cunningham AM; Gish GD; Pawson T; Pai EF
    Mol Cell; 2000 Jun; 5(6):1043-9. PubMed ID: 10911998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.
    Merő B; Radnai L; Gógl G; Tőke O; Leveles I; Koprivanacz K; Szeder B; Dülk M; Kudlik G; Vas V; Cserkaszky A; Sipeki S; Nyitray L; Vértessy BG; Buday L
    J Biol Chem; 2019 Mar; 294(12):4608-4620. PubMed ID: 30659095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.
    Young MA; Gonfloni S; Superti-Furga G; Roux B; Kuriyan J
    Cell; 2001 Apr; 105(1):115-26. PubMed ID: 11301007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Itk/Tsk Src homology 3 domain ligands.
    Bunnell SC; Henry PA; Kolluri R; Kirchhausen T; Rickles RJ; Berg LJ
    J Biol Chem; 1996 Oct; 271(41):25646-56. PubMed ID: 8810341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide.
    Narula SS; Yuan RW; Adams SE; Green OM; Green J; Philips TB; Zydowsky LD; Botfield MC; Hatada M; Laird ER
    Structure; 1995 Oct; 3(10):1061-73. PubMed ID: 8590001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.